Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06367088
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-04-10
Brief Title:
Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer
Sponsor:
Organization:
Wuhan Union Hospital China